Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Chronic Illness

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Chronic Illness in 2 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Souza, FC1
Gobbato, NB1
Maciel, RG1
Prado, CM1
Martins, MA1
Leick, EA1
Tibério, IF1
Zhang, P1
Xu, X1
Hu, X1
van Deel, ED1
Zhu, G1
Chen, Y1

Other Studies

2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Chronic Illness

ArticleYear
Effects of corticosteroid, montelukast and iNOS inhibition on distal lung with chronic inflammation.
    Respiratory physiology & neurobiology, 2013, Jan-15, Volume: 185, Issue:2

    Topics: Acetates; Amidines; Animals; Anti-Inflammatory Agents; Benzylamines; Chronic Disease; Cyclopropanes;

2013
Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
    Circulation research, 2007, Apr-13, Volume: 100, Issue:7

    Topics: Amidines; Animals; Aortic Diseases; Atrial Natriuretic Factor; Benzylamines; Cardiomegaly; Chronic D

2007